Lead Sponsor

Centre Hospitalier de Valenciennes

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Any adult patient over 18 years of age
•Patient treated with the CareMin650™ photobiomodulation device, as a preventive or curative measure for oral mucositis and/or radiodermatitis induced by chemotherapy (in the broadest sense: includes targeted therapies, immunotherapy) and/or radiotherapy, as part of their routine management for any type of cancer or haematological malignancy, whatever the stage and prognosis of the disease
•Information note sent to the patient and record of the patient's or legal representative's (guardian's) non-objection
•Membership of a social security scheme

•Pregnant women
•Patient with severe cognitive impairment rendering him/her incapable of expressing non-objection to participation in the study.
•If the patient is under guardianship or curatorship: objection from the guardian/curator.
•Patient with a known allergy to polyurethane
•Patient taking part in a clinical study involving medicinal or non-medicinal therapies to treat or prevent oral mucositis or radiodermatitis.
•Patients physically unable to apply Ora-Pad and Derma-Pad devices (e.g. limited mouth opening).

Related studies

NCT06708702 · Oral Mucositis, Oral Mucositis (Ulcerative) Due to Radiation, and more

NCT07312656 · Oral Mucositis (Ulcerative) Due to Radiation

NCT07186114 · Oral Mucositis (Ulcerative) Due to Radiation

NCT03972527 · Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, and more

NCT04870060 · Oral Mucositis (Ulcerative)

Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis